Complete sequence of the genome of avian paramyxovirus type 9 and comparison with other paramyxoviruses
- PMID: 19185593
- PMCID: PMC2782688
- DOI: 10.1016/j.virusres.2008.12.016
Complete sequence of the genome of avian paramyxovirus type 9 and comparison with other paramyxoviruses
Abstract
The complete genome consensus sequence was determined for avian paramyxovirus (APMV) serotype 9 prototype strain PMV-9/domestic Duck/New York/22/78. The genome is 15,438 nucleotides (nt) long and encodes six non-overlapping genes in the order of 3'-N-P/V/W-M-F-HN-L-5' with intergenic regions of 0-30 nt. The genome length follows the "rule of six" and contains a 55-nt leader sequence at the 3' end and a 47-nt trailer sequence at the 5' end. The cleavage site of the F protein is I-R-E-G-R-I downward arrowF, which does not conform to the conventional cleavage site of the ubiquitous cellular protease furin. The virus required exogenous protease for in vitro replication and grew only in a few established cell lines, indicating a restricted host range. Alignment and phylogenetic analysis of the predicted amino acid sequences of APMV-9 proteins with the cognate proteins of viruses of all five genera of family Paramyxoviridae showed that APMV-9 is more closely related to APMV-1 than to other APMVs. The mean death time in embryonated chicken eggs was found to be more than 120h, indicating APMV-9 to be avirulent for chickens.
Figures






References
-
- Alexander DJ. Avian paramyxoviruses other than Newcastle disease virus. World’s Poul Sci J. 1982;38:97–104.
-
- Alexander DJ. Avian Paramyxoviruses. Iowa State University Press; Ames: 2003. pp. 2–9.
-
- Alexander DJ. OIE Manual. 5. 1 and 2. OIE; 2008. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals; pp. 576–589.
-
- Alexander DJ, Hinshaw VS, Collins MS, Yamane N. Characterization of viruses which represent further distinct serotypes (PMV-8 and PMV-9) of avian paramyxoviruses. Arch Virol. 1983;78:29–36. - PubMed
-
- Beck I, Gerlach H, Burkhardt E, Kaleta EF. Investigation of several selected adjuvants regarding their efficacy and side effects for the production of a vaccine for parakeets to prevent a disease caused by a paramyxovirus type 3. Vaccine. 2003;21:1006–1022. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials